Xoma | XOMA - Pre Tax Profit

Stock Price
26.53
Daily Change
0.15 0.57%
Monthly
8.42%
Yearly
29.83%
Q1 Forecast
25.58

Xoma reported $15.98M in Pre-Tax Profit for its fiscal quarter ending in June of 2024.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Agenus USD -274.14M 80.46M Sep/2025
Agios Pharmaceuticals USD -109.06M 5.62M Dec/2025
Ardelyx USD -867K 18.21M Sep/2025
aTyr Pharma USD -25.75M 6.22M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Celldex Therapeutics USD -81.32M 14.27M Dec/2025
Curis USD -13.99M 7.38M Jun/2025
Eli Lilly USD 7.23B 456M Sep/2025
Incyte USD 389.94M 92.37M Dec/2025
MacroGenics USD 16.82M 52.97M Sep/2025
Novartis USD 4.2B 335M Sep/2025
Novartis USD 5.17B 637M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Prothena USD -36.91M 44.05M Sep/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Xoma USD 15.98M 24.58M Jun/2024